chr17-35575229-TAAC-T
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_000286.3(PEX12):c.*550_*552delGTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0237 in 155,410 control chromosomes in the GnomAD database, including 123 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.024 ( 121 hom., cov: 32)
Exomes 𝑓: 0.020 ( 2 hom. )
Consequence
PEX12
NM_000286.3 3_prime_UTR
NM_000286.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.903
Genes affected
PEX12 (HGNC:8854): (peroxisomal biogenesis factor 12) This gene belongs to the peroxin-12 family. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of Zellweger syndrome (ZWS). [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 17-35575229-TAAC-T is Benign according to our data. Variant chr17-35575229-TAAC-T is described in ClinVar as [Likely_benign]. Clinvar id is 322642.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.168 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0238 AC: 3623AN: 152168Hom.: 122 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3623
AN:
152168
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0195 AC: 61AN: 3124Hom.: 2 AF XY: 0.0177 AC XY: 29AN XY: 1638 show subpopulations
GnomAD4 exome
AF:
AC:
61
AN:
3124
Hom.:
AF XY:
AC XY:
29
AN XY:
1638
Gnomad4 AFR exome
AF:
AC:
0
AN:
8
Gnomad4 AMR exome
AF:
AC:
13
AN:
734
Gnomad4 ASJ exome
AF:
AC:
0
AN:
12
Gnomad4 EAS exome
AF:
AC:
13
AN:
70
Gnomad4 SAS exome
AF:
AC:
8
AN:
322
Gnomad4 FIN exome
AF:
AC:
1
AN:
10
Gnomad4 NFE exome
AF:
AC:
23
AN:
1856
Gnomad4 Remaining exome
AF:
AC:
3
AN:
110
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0238 AC: 3619AN: 152286Hom.: 121 Cov.: 32 AF XY: 0.0258 AC XY: 1923AN XY: 74438 show subpopulations
GnomAD4 genome
AF:
AC:
3619
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
1923
AN XY:
74438
Gnomad4 AFR
AF:
AC:
0.00630141
AN:
0.00630141
Gnomad4 AMR
AF:
AC:
0.00823745
AN:
0.00823745
Gnomad4 ASJ
AF:
AC:
0.0109447
AN:
0.0109447
Gnomad4 EAS
AF:
AC:
0.177825
AN:
0.177825
Gnomad4 SAS
AF:
AC:
0.0476981
AN:
0.0476981
Gnomad4 FIN
AF:
AC:
0.0393322
AN:
0.0393322
Gnomad4 NFE
AF:
AC:
0.0234609
AN:
0.0234609
Gnomad4 OTH
AF:
AC:
0.0146641
AN:
0.0146641
Heterozygous variant carriers
0
179
359
538
718
897
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
315
AN:
3476
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Peroxisome biogenesis disorder 1A (Zellweger) Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at